Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection

Journal of Rheumatology

Volumn 27, Issue 3, 2000, Pages 610-612

  Kessel, Aharon ^a   Rosner, Itzhak ^a   Zuckerman, Eli ^a   Golan, Theo Dov ^a   Toubi, Elias ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Antikeratin antibodies; Hepatitis C virus; Rheumatoid arthritis

Indexed keywords

KERATIN ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIBODIES; ARTHRITIS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS C; HUMANS; IMMUNOLOGIC TESTS; KERATINS; MALE; MIDDLE AGED;

EID: 0034056452     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bon E, Cantarel A, Moulinier L, et al. Rheumatic manifestation of chronic hepatitis C and response to treatment with interferon alpha. Rev Rhum 1994;61:497-9.
2. Siegel LB, Cohn L, Nashel D. Rheumatic manifestation of hepatitis C infection. Semin Arthritis Rheum 1993;23:149-54.
3. Ueno Y, Kinoshita R, Kishimoto I, et al. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994;33:289-91.
4. Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-9.
5. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestation in chronic hepatitis C virus serotypes. Ann Intern Med 1995;122:169-73.
6. Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis-C virus associated glomerulonephritis: effect of alpha interferon. Kidney Int 1994;46:1700-4.
7. Johnson GD, Carvalho A, Holborow EJ, Goddard DH, Russell G. Antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. Ann Rheum Dis 1981;40:263-6.
8. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ. Antikeratin antibodies in rheumatoid arthritis. BMJ 1979;2:97-9.
9. Kataaha PK, Mortazavi-Milani SM, Russell G, Holborow EJ. Anti-intermediate filament antibodies, antikeratin antibodies and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis. Ann Rheum Dis 1985;44:446-9.
10. Quismorio PF, Kaufman RL, Beardmore T, Mongan ES. Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum 1983;26:494-9.
11. Kirnstein H, Mathiesen KF. Antikeratin antibodies in rheumatoid arthritis. Scand J Rheumatol 1983;16:331-7.
12. Youinou P, Le Goff P, Colaco CB, et al. Antikeratin antibodies in serum and synovial fluid show specificity for RA in a study of connective tissue diseases. Ann Rheum Dis 1985;44:450-4.
13. Scott DL, Delamere JP, Jones LJ, Walton KW. Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Ann Rheum Dis 1981;40:267-71.
14. Mallya RK, Young BJJ, Pepys MB, et al. Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease. Clin Exp Immunol 1983;51:17-20.
15. Vincent C, Serre G, Lapeyre F, et al. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called "antikeratin antibodies". Ann Rheum Dis 1989;48:712-22.
16. Simon M, Girabal E, Sebbag M, Gomes-Daudrix V, et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993:92:1387-93.
17. McMurray RW. Heptitis C-associated autoimmune disorders. Rheum Dis Clin North Am 1998;24:353-76.
18. Hirohata S, Inoue T, Ito K. HCV infection and RA: differential expression of anti-c100-3 and anti-GOR antibodies [letter]. J Rheumatol 1993;20:204-5.
19. Rosner I, Rozenbaum M, Zuckerman E, Naschitz Y. Rheumatoid-like arthritis associated with hepatitis C. J Clin Rheumatol 1995;1:182-4.
20. Euller-Ziegler L, Chami H, Grisot C, et al. Rheumatoid arthritis and hepatitis C virus infection [abstract]. Arthritis Rheum 1995; Suppl 38:S200.
21. Garcia-Monforte A, Romero M, de Diego A, Rivera J. Rheumatic and autoimmune manifestations in chronic hepatitis C virus infection [abstract]. Arthritis Rheum 1995; Suppl 38:S200.
22. Monder KG, Lindor K. Musculoskeletal symptoms in patients with hepatitis C. J Clin Rheumatol 1996;2:234-5.
23. Zuckerman E, Rosner I, Ashkar M, et al. Rheumatologic and immunologic manifestations of hepatitis C infection [abstract]. Hepatology 1995;22:A352.
24. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994;107:196-9.
26. Maruta A, Kanamori H, Fukawa H, et al. Liver function tests of recipients with hepatitis C virus infection after bone marrow transplantation. Bone Marrow Transplantation 1994;13:417-22.
27. Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of RA. J Rheumatol 1996;23:979-83.
28. Buskila D, Shnaider A, Neumann L, et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998;28:107-13.